Valuation Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 25/06/2026			5-day change	1st Jan Change
2,725.00 ^MXN	+0.93%		+6.32%	+9.00%

06-26	Swiss pharma at risk of US trade investigation, industry body says	RE
06-26	Swiss Market Index Snaps Gains; ABB Shares Down	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	286,017	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	7.52%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	318,244	314,759	309,019
Change	-	-0.57%	7.71%	-2.61%	35.8%	9.79%	-1.1%	-1.82%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	21.7x	18.4x	15.9x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.52x	6.1x	5.48x
PEG	-	-0.4x	0x	-1x	0.9x	-244.46x	1x	1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	5.02x	4.74x	4.46x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.59x	5.21x	4.82x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	13.5x	12.4x	11.2x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14.8x	13.5x	12.2x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	23.5x	19.4x	16.6x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.25%	5.16%	6.04%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.418	4.563	4.751
Rate of return	3.83%	3.87%	3.79%	3.94%	-	2.83%	2.92%	3.04%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.204	8.49	9.803
Distribution rate	31.4%	110%	53.5%	65.1%	-	61.3%	53.8%	48.5%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	56,922	60,404	64,137
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,561	25,425	27,652
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,517	23,322	25,312
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,157	15,730	17,651
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,227	28,742	23,002
Reference price ²	87.82	90.40	100.79	97.79	138.63	156.25	156.25	156.25
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,830,549	-	-
Announcement Date	2/2/22 A	2/1/23 A	1/31/24 A	1/31/25 A	2/4/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
PFIZER INC.	11.36x	3.03x	7.37x	7.21%	138B
Average	15.47x	6.21x	15.86x	2.92%	385.39B
Weighted average by Cap.	24.15x	7.94x	18.28x	2.11%